Myomo Inc. (MYO) — Analysis Summary
Myomo Inc. (MYO) has a market cap of $37.48M with year-over-year revenue growth of +25.7%. Net margin stands at -38.1%. The stock trades at a P/E ratio of -2.5.
Key Takeaways
- Revenue changed +25.7% year-over-year
- Net margin of -38.1%
- P/E ratio of -2.5
Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, MYO posted revenue growth of +25.7% and trades at a P/E of -2.5.
Myomo Inc. (MYO)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Operating margin at -34.1% — material operating losses
Net margin at -36.7% — significant losses
The latest filing shows negative free cash flow.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Employees
195
Headquarters
BOSTON, MA
Exchange
XASE
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.